Treatment of rheumatoid arthritis: a global perspective on the use of antirheumatic drugs

References

• Kelley WN, Harris ED Jr, Ruddy S, Sledge CB. Textbook of Rheumatology. 2nd ed. Philadelphia: W.B.Saunders; 1985.
   Google Scholar
• Short CL, Bauer W. The course of rheumatoid arthritis in patients receiving simple medical and orthopedic measures. N Engl J Med. 1948;238:142–8.
   PubMed Web of Science ®Google Scholar
• Pincus T, Callahan LF, Sale WG, Brooks AL, Payne LE, Vau-ghn WK. Severe functional declines, work disability, and increased mortality in seventy-five rheumatoid arthritis patients studied over nine years. Arthritis Rheum. 1984;27:864–72.
   Google Scholar
• Scott DL, Grindulis KA, Struthers GR, Coulton BL, Popert AJ, Bacon PA. Progression of radiological changes in rheumatoid arthritis. Ann Rheum Dis. 1984;43:8–17.
   PubMed Web of Science ®Google Scholar
• Yelin E, Meenan R, Nevitt M, Epstein W. Work disability in rheumatoid arthritis: effects of disease, social, and work factors. Ann Intern Med. 1980;93:551–6.
   PubMed Web of Science ®Google Scholar
• Wilske KR, Healey LA. Remodeling the pyramid-a concept whose time has come. J Rheumatol. 1989;16:565–7.
   PubMed Web of Science ®Google Scholar
• Fries JF. Reevaluating the therapeutic approach to rheumatoid arthritis: the "sawtooth" strategy. J Rheumatol. 1990;17 Suppl 22:12–5.
   Google Scholar
• Emery P, Salmon M. Early rheumatoid arthritis: time to aim for remission? Ann Rheum Dis. 1995;54:944–7.
   Google Scholar
• Luukkainen R, Kajander A, Isomäki H. Effect of gold on pro-gression of erosions in rheumatoid arthritis: better results with early treatment. Scand J Rheumatol. 1977;6:189–92.
   Google Scholar
• Luukkainen R, Kajander A, Isomäki H. Treatment of rheuma-toid arthritis (letter). Br Med J. 1978;2:1501.
   Google Scholar
• Pincus T, Gibofsky A, Weinblatt ME. Urgent care and tight control of rheumatoid arthritis as in diabetes and hypertension: better treatments but a shortage of rheumatologists. Arthritis Rheum. 2002;46(4):851–4.
   Google Scholar
• Kellgren JH, Bier F. Radiological signs of rheumatoid arthritis: a study of observer differences in the reading of hand films. Ann Rheum Dis. 1956;15:55–60.
   PubMed Web of Science ®Google Scholar
• Lawrence JS, Bennett PH. Benign polyarthritis. Ann Rheum Dis. 1960;19:20–30.
   PubMed Web of Science ®Google Scholar
• Mikkelsen WM, Dodge H. A four year follow-up of suspected rheumatoid arthritis: the Tecumseh, Michigan, community health study. Arthritis Rheum. 1969;12:87–91.
   PubMed Web of Science ®Google Scholar
• O'Sullivan JB, Cathcart ES. The prevalence of rheumatoid arthritis: follow-up evaluation of the effect of criteria on rates in Sudbury, Massachusetts. Ann Intern Med. 1972;76:573–7.
   PubMed Web of Science ®Google Scholar
• Nissild M, Isomäki H, Kaarela K, Kiviniemi P, Martio J, Sarna S. Prognosis of inflammatory joint diseases. A three-year fol-low-up study. Scand J Rheumatol. 1983;12:33–8.
   PubMedGoogle Scholar
• Emery P, Gough A. Why early arthritis clinics? Br J Rheumatol. 1991;30:241–2.
   Google Scholar
• Scott DL, Symmons DP, Coulton BL, Popert AJ. Long-term outcome of treating rheumatoid arthritis: Results after 20 years. Lancet. 1987;16:1108–11.
   Google Scholar
• Symmons DPM, Hazes JMW, Silman AJ. Cases of early inflammatory polyarthritis should not be classified as having rheumatoid arthritis. J Rheumatol. 2003;30:902–4.
   Google Scholar
• Allbutt T, Rolleston H. A system of medicine. London: Macmillan, 1907.
   Google Scholar
• Amett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31:315–24.
   PubMed Web of Science ®Google Scholar
• Harrison BJ, Symmons DPM, Barrett EM, Silman AJ. The performance of the 1987 ARA classification criteria for rheu-matoid arthritis in a population based cohort of patients with early inflammatory polyarthritis. J Rheumatol. 1998;25:2324–30.
   PubMed Web of Science ®Google Scholar
• Saraux A, Berthelot JM, Chalès G, Le Henaff C, 'Thorel JB, Hoang S, et al. Ability of the American College of Rheuma-tology 1987 criteria to predict rheumatoid arthritis in patients with early arthritis and classification of these patients two years later. Arthritis Rheum. 2001;44(11):2485–91.
   Google Scholar
• Wolfe F, Michaud K. The clinical and research significance of the erythrocyte sedimentation rate. J Rheumatol. 1994;21:1227–37.
   PubMed Web of Science ®Google Scholar
• Pincus T, Sokka T. Prevalence of normal erythrocyte sedimen-tation rate (ESR) and C-reactive protein (CRP) on presentation of patients with rheumatoid arthritis (RA) at two rheumatology settings, one in the US and the other in Finland: Is a patient questionnaire a better quantitative measure of clinical severity? Arthritis Rheum. 2005;52(9):S127.
   Google Scholar
• Pincus T, Callahan LF. The 'side effects' of rheumatoid arthritis: Joint destruction, disability and early mortality. Br J Rheumatol. 1993;32\(suppl 1):28–37.
   Google Scholar
• van Dongen H, van Aken J, Lard LR, Ronday H.K, Hulsmans H.M.J., Speyer I, et al. Efficacy of methotrexate treatment in patients with probable rheumatoid arthritis: a double-blind, randomized, placebo-controlled trial. Arthritis Rheum. 2007;56:1424–32.
   Google Scholar
• Möttönen T, Hannonen P, Korpela M, Nissild M, Kautiainen H, Ilonen J, et al. Delay to institution of therapy and induction of remission using single-drug or combination-disease-modifying antirheumatic drug therapy in early rheumatoid arthritis. Arthritis Rheum. 2002;46(4):894–8.
   Google Scholar
• Puolakka K, Kautiainen H, Mottonen T, Hannonen P, Korpela M, Hakala M, et al. Early suppression of disease activity is essential for maintenance of work capacity in patients with recent-onset rheumatoid arthritis: five-year experience from the FIN-RACo trial. Arthritis Rheum. 2005;52(1):36–41.
   PubMed Web of Science ®Google Scholar
• Grigor C, Cape11 H, Stirling A, McMahon AD, Lock P, Vallance R, et al. Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind ran-domised controlled trial. Lancet. 2004;364: 263–9.
   Google Scholar
• Paulus HE. Defining remission in rheumatoid arthritis: what is it? does it matter? J Rheumatol. 2004;31(1):1–4.
   PubMedGoogle Scholar
• Combe B, Landewe R, Lukas C, Bolosiu HD, Breedveld F, Dougados M, et al. EULAR recommendations for the manage-ment of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis. 2007;66(1):34–45.
   PubMed Web of Science ®Google Scholar
• Pincus T, Yazici Y, Sokka T, Aletaha D, Smolen JS. Metho-trexate as the "anchor drug" for the treatment of early rheumatoid arthritis. Clin Exp Rheumatol. 2003;21:S179–85.
   Google Scholar
• Kremer JM. Toward a better understanding of methotrexate. Arthritis Rheum. 2004;50(5):1370–82.
   PubMed Web of Science ®Google Scholar
• Pincus T, Marcum SB, Callahan LF. Long-term drug therapy for rheumatoid arthritis in seven rheumatology private practices: II. Second-line drugs and prednisone. J Rheumatol. 1992;19:1885–94.
   Google Scholar
• Wolfe F, Hawley DJ, Cathey MA. Termination of slow acting anti-rheumatic therapy in rheumatoid arthritis: A 14-year pro-spective evaluation of 1017 consecutive starts. J Rheumatol. 1990;17: 994–1002.
   Google Scholar
• Leirisalo-Repo M, Mottonen THP, Korpela M, Kauppi M, Kaipiainen-Seppanen 0, Luosujarvi R et al. Does addition of infliximab to triple DMARD plus prednisolone therapy increase rate of remissions in patients with early active rheumatoid arthritis? A randomized double-blind placebo-controlled study. Arthritis Rheum; 2006:54(9 Suppl).
   Google Scholar
• Sokka T, Hannonen P, Mottonen T. Conventional disease-modifying antirheumatic drugs in early arthritis. Rheum Dis Clin N Am. 2005;31(4):729–44.
   PubMedGoogle Scholar
• Miyasaka N, Koike R. Treatment guidelines for the use of biologics in rheumatoid arthritis; present and future. Nippon Rinsho. 2007;65(7):1169–78.
   PubMedGoogle Scholar
• Bergstrom U, Book C, Lindroth Y, Marsal L, Saxne T, Jacobsson L. Lower disease activity and disability in Swedish patients with rheumatoid arthritis in 1995 compared with 1978. Scand J Rheumatol. 1999;28:160–5.
   PubMed Web of Science ®Google Scholar
• Pincus T, Sokka T, Kautiainen H. Patients seen for standard rheumatoid arthritis care have significantly better articular, radiographic, laboratory, and functional status in 2000 than in 1985. Arthritis Rheum. 2005;52: 1009–19.
   Google Scholar
• Sokka T, Möttonen T, Hannonen P. Disease-modifying anti-rheumatic drug use according to the `sawtooth' treatment strategy improves the functional outcome in rheumatoid arthri-tis: Results of a long-term follow-up study with review of the literature. Rheumatology. 2000;39:34–42.
   PubMedGoogle Scholar
• Krishnan E, Fries JF. Reduction in long-term functional dis-ability in rheumatoid arthritis from 1977 to 1998: a longitudinal study of 3035 patients. Am J Med. 2003;115:371–6.
   PubMed Web of Science ®Google Scholar
• Heiberg T, Finset A, Uhlig T, Kvien TK. Seven year changes in health status and priorities for improvement of health in patients with rheumatoid arthritis. Ann Rheum Dis. 2005;64:191–5.
   PubMed Web of Science ®Google Scholar
• Sokka TM, Kaarela K, Mottonen TT, Hannonen PJ. Conven-tional monotherapy compared to a "sawtooth" treatment strategy in the radiographic procession of rheumatoid arthritis over the first eight years. Clin Exp Rheumatol. 1999;17:527–32.
   PubMedGoogle Scholar
• Sokka T, Kautiainen H, Hlikkinen K, Hannonen P. Radiographic progression is getting milder in patients with early rheumatoid arthritis. Results of 3 cohorts over 5 years. J Rheumatol. 2004;31:1073–82.
   Google Scholar
• Sokka T, Kautiainen H, Hannonen P. Stable occurrence of knee and hip total joint replacement in Central Finland between 1986 and 2003: an indication of improved long-term outcomes of rheumatoid arthritis. Ann Rheum Dis. 2007;66(3):341–4.
   Google Scholar
• Krause D, Schleusser B, Herborn G, Rau R. Response to methotrexate treatment is associated with reduced mortality in patients with severe rheumatoid arthritis. Arthritis Rheum. 2000;43:14–21.
   PubMed Web of Science ®Google Scholar
• Choi HK, Hernán MA, Seeger JD, Robins JM, Wolfe F. Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study. Lancet. 2002;359:1173–7.
   PubMed Web of Science ®Google Scholar
• Silman A, Davies P, Currey HLF, Evans SJW. Is rheumatoid arthritis becoming less severe? J Chronic Dis. 1983;36:891–7.
   Google Scholar
• Aho K, Tuomi T, Palosuo T, Kaarela K, von Essen R, Isomaki H. Is seropositive rheumatoid arthritis becoming less severe? Clin Exp Rheumatol. 1989;7:287–90.
   Google Scholar
• Sokka T, Kautiainen H, Toloza S, Makinen H, Verstappen SM, Lund HM, et al. QUEST-RA: quantitative clinical assessment of patients with rheumatoid arthritis seen in standard rheumatology care in 15 countries. Ann Rheum Dis. 2007;66(11):1491–6.
   PubMed Web of Science ®Google Scholar
• Aletaha D, Smolen JS. The rheumatoid arthritis patient in the clinic: comparing more than 1300 consecutive DMARD courses. Rheum. 2002;41:1367–74.
   Google Scholar
• Jobanputra P, Wilson J, Douglas K, Burls A. A survey of British rheumatologists' DMARD preferences for rheumatoid arthritis. Rheumatology. 2003;42:1–5.
   Google Scholar
• Hider SL, Silman AJ, Bunn D, Manning S, Symmons DP, Lunt M. Comparing the long-term clinical outcome between met-hotrexte and sulfasalazine prescribed as the first DMARD in patients with inflammatory polyarthritis. Ann Rheum Dis. 2006; 65(11):1449–55.
   PubMedGoogle Scholar
• Welsing PMJ, Fransen J, van Riel PLCM. Is the disease course of rheumatoid arthritis becoming milder? Time trends since 1985 in an inception cohort of early rheumatoid arthritis. Arthritis Rheum. 2005;52:2616–24.
   Google Scholar
• Willkens RF, Watson MA, Paxson CS. Low dose pulse meth-otrexate therapy in rheumatoid arthritis. J Rheumatol. 1980;7:501–5.
   Google Scholar
• Hoffmeister RT. Methotrexate therapy in rheumatoid arthritis: 15 years experience. Am J Med. 1983;75(suppl 6A):69–73.
   Google Scholar
• Kremer JM. Methotrexate update. Scan J Rheumatol. 1996;25:341–4.
   PubMed Web of Science ®Google Scholar
• Suzuki Y. Methotrexate for the treatment of rheumatoid arthritis in Japan-much more still remains to be resolved. Nippon Rinsho. 2002;60(12):2331–8.
   PubMedGoogle Scholar
• Jacoby RK, Jayson MIV, Cosh JA. Onset, early stages, and prognosis of rheumatoid arthritis: a clinical study of 100 patients with 11-year follow-up. Br Med J. 1973;2: 96–100.
   Google Scholar
• Minaur N, Jacoby R, Cosh J, Taylor G, Rasker J. Outcome after 40 years with rheumatoid arthritis: a prospective study of function, disease activity and mortality. J Rheumatol. 2004;31(569):3–8.
   Google Scholar
• Kaarela K. Prognostic factors and diagnostic criteria in early rheumatoid arthritis. Scand J Rheumatol Suppl. 1985;57:1–54.
   PubMedGoogle Scholar
• Sokka T. Early rheumatoid arthritis in Finland. Clin Exp Rheumatol. 2003;21:S133–7.
   Google Scholar
• Jantti JK, Kaarela K, Belt EA, Kautiainen HJ. Incidence of severe outcome in rheumatoid arthritis during 20 years. J Rheumatol. 2002;29(4):688–92.
   PubMedGoogle Scholar
• Kaarela K, Kautiainen H. Continuous progression of radiologi-cal destruction in seropositive rheumatoid arthritis. J Rheumatol. 1997;24:1285–7.
   PubMedGoogle Scholar
• Welsing PM, van Riel PL. The Nijmegen inception cohort of early rheumatoid arthritis. J Rheumatol Suppl. 2004;69:14–21.
   PubMedGoogle Scholar
• Häkkinen A, Sokka T, Kotaniemi A, Hannonen P. A randomized two-year study of the effects of dynamic strength training on muscle strength, disease activity, functional capacity, and bone mineral density in early rheumatoid arthritis. Arthritis Rheum. 2001;44:515–22.
   Google Scholar
• Sokka T, Pincus T. Contemporary disease modifying antirheu-matic drugs (DMARD) in patients with recent onset rheumatoid arthritis in a US private practice: methotrexate as the anchor drug in 90% and new DMARD in 30% of patients. J Rheumatol. 2002;29(12):2521–4.
   PubMedGoogle Scholar
• Sokka TM, Kautiainen HJ, Hannonen PJ. A retrospective study of treating RA patients with various combinations of slow-acting antirheumatic drugs in a county hospital. Scand J Rheumatol. 1997;26:440–3.
   Google Scholar
• Klaukka T, Kaarela K. Methotrexate is the leading DMARD in Finland. Ann Rheum Dis. 2003;62:494–6.
   PubMedGoogle Scholar
• Finckh A, Choi HK, Wolfe F. Progression of radiographic joint damage in different eras: trends towards milder disease in rheumatoid arthritis are attributable to improved treatment. Ann Rheum Dis. 2006;65(9):1192–7.
   Google Scholar
• Sokka T. Rheumatoid arthritis databases. Rheum Dis Clin North Am. 2004;30(4):769–81.
   PubMedGoogle Scholar
• Pincus T, Sokka T. Uniform databases in early arthritis: specific measures to complement classification criteria and indices of clinical change. Clin Exp Rheumatol. 2003;21:579–88.
   Google Scholar
• Sokka T, Pincus T. Quantitative joint assessment in rheumatoid arthritis. Clin Exp Rheumatol. 2005;23:558–62.
   Google Scholar
• Jantti J, Kaarela K, Kautiainen H, Isomaki H, Aho K. Radio-graphic remission in seropositive rheumatoid arthritis. A 20-year follow-up study. Clin Exp Rheumatol. 2001;19: 573–6.
   Google Scholar
• Young A, Dixey J, Cox N, Davies P, Devlin J, Emery P, et al. How does functional disability in early rheumatoid arthritis (RA) affect patients and their live? Results of 5 years of follow-up in 732 patients from the Early RA Study (ERAS). Rheu-matology. 2000;39:603–11.
   PubMed Web of Science ®Google Scholar
• Bukhari MAS, Wiles NJ, Lunt M, Harrison BJ, Scott DGI, Symmons DPM, et al. Influence of disease-modifying therapy on radiographic outcome in inflammatory polyarthritis at five years: results from a large observational inception study. Arthritis Rheum. 2003;48:46–53.
   PubMed Web of Science ®Google Scholar
• Papadopoulos NG, Alamanos Y, Papadopoulos IA, Tsifetaki N, Voulgari PV, Drosos AA. Disease modifying antirheumatic drugs in early rheumatoid arthritis: a longterm observational study. J Rheumatol. 2002;29:261–6.
   PubMed Web of Science ®Google Scholar
• Paulus HE, Ramos B, Wong WK, Ahmed A, Bulpitt K, Park G, et al. Equivalence of the acute phase reactants C-reactive protein, plasma viscosity, and Westergren erythrocyte sedmientation rate when used to calculate American College of Rheumatology 20% improvement criteria or the disease activity score in patients with rearly rheumatoid arthritis. Western Consortium of Practicing Rheumatologists. J Rheumatol. 1999;26(11):2324–32.
   Google Scholar
• Forslind K, Ahlmen M, Eberhardt K, Hafstrom I, Svensson B. Prediction of radiological outcome in early rheumatoid arthritis in clinical practice: role of antibodies to citrullinated peptides (anti-CCP). Ann Rheum Dis. 2004;63(9):1090–5.
   Google Scholar
• Makinen H, Kautiainen H, Hannonen P, Sokka T. Frequency of remissions in early rheumatoid arthritis defined by 3 sets of criteria. A 5-year followup study. J Rheumatol. 2005;32:796–800.
   PubMedGoogle Scholar
• Carli C, Ehlin AG, Klareskog L, Lindblad S, Montgomery SM. Trends in disease modifying antirheumatic drug prescription in early rheumatoid arthritis are influenced more by hospital setting than patient or disease characteristics. Ann Rheum Dis. 2006;65(8):1102–5.
   Google Scholar
• Bombardier C, Deaton RL, Gregersen P, Massarotti E, Formica C, Weisman MH. Pattern of DMARD use in a North American cohort of patients with early rheumatoid arthritis (RA) (SONORA). Arthritis Rheum. 2002;46(95):5344.
   Google Scholar
• GIARA Registry Study Group. Aggressive rheumatoid arthritis registry in Italy. Characteristics of the early rheumatoid arthritis subtype among patients classified according to the ACR criteria. Clin Exp Rheumatol. 2003;21:S129–32.
   Google Scholar
• Rasker JJ, Cosh JA. Radiological study of cervical spine and hand in patients with rheumatoid arthritis of 15 years' duration: an assessment of the effects of corticosteroid treatment. Ann Rheum Dis. 1978;37:529–35.
   PubMed Web of Science ®Google Scholar
• Rlise T, Jacobsen BK, Gran JT. Changes in therapy of rheu-matoid arthritis during the period 1979 to 1996. Scan J Rheumatol. 2001;30: 199–202.
   Google Scholar
• Edwards CJ, Arden NK, Fisher D, Saperia JC, Reading I, Van Staa TP, et al. The changing use of disease-modifying anti-rheumatic drugs in individuals with rheumatoid arthritis from the United Kingdom General Practice Research Database. Rheumatology (Oxford). 2005;44(11):1394–8.
   Google Scholar
• van Schaardenburg D, Hazes JM, de Boer A, Zwinderman AH, Meijers KA, Breedveld FC. Outcome of rheumatoid arthritis in relation to age and rheumatoid factor at diagnosis. J Rheumatol. 1993;20(1):45–52.
   PubMedGoogle Scholar
• Hamada Y, Shinomiya F, Okada M, Fujimura T. Outcome of patients with rheumatoid arthritis treated by step-wise admin-istration of disease-modifying antirheumatic drugs over a 10-year period. Mod Rheumatol. 2003;13:27–34.
   PubMedGoogle Scholar
• Gordon P, West J, Jones H, Gibson T. A 10 year prospective followup of patients with rheumatoid arthritis 1986-96. J Rheumatol. 2001;28(11):2400–8.
   PubMedGoogle Scholar
• Kvien TK, Uhlig T, Kristiansen IS. Criteria for TNF-targeted therapy in rheumatoid arthritis: estimates of the number of patients potentially eligible. Drugs. 2001;61:1711–20.
   Google Scholar
• Soderlin MK, Lindroth Y, Jacobsson LT. Trends in medication and health-related quality of life in a population-based rheu-matoid arthritis register in Malmo, Sweden. Rheumatology (Oxford). 2007;46(8):1355–8.
   Google Scholar
• Eberhardt K, Fex E. Clinical course and remission rate in patients with early rheumatoid arthritis: relationship to outcome after 5 years. Br J Rheumatol. 1998;37:1324–9.
   PubMedGoogle Scholar
• Lindqvist E, Saxne T, Geborek P, Eberhardt K. Ten year out-come in a cohort of patients with early rheumatoid arthritis: health status, disease process, and damage. Ann Rheum Dis. 2002;61:1055–9.
   PubMed Web of Science ®Google Scholar
• Dadoniene J, Uhlig T, Stropuviene S, Venalis A, Boonen A, Kvien TK. Disease activity and health status in rheumatoid arthritis: a case-control comparison between Norway and Lith-uania. Ann Rheum Dis. 2003;62(3):231–5.
   PubMedGoogle Scholar
• Gonzalez-Alvaro I, Carmona L, Balsa A, Sanmarti R, Belmonte MA, Tena X, et al. Patterns of disease modifying antirheumatic drug use in a Spanish cohort of patients with rheumatoid arthritis. J Rheumatol. 2003;30:697–704.
   Google Scholar
• Thiele K, Buttgereit F, Huscher D, Zink A. Current use of glucocorticoids in patients with rheumatoid arthritis in Germany. Arthriis Rheum. 2005;53(5):740–7.
   PubMed Web of Science ®Google Scholar
• Kvien TK, Heiberg MS, Lie E, Kaufmann C, Mikkelsen K, Nordvag B-Y, et al. A Norwegian DMARD register: prescrip-tions of DMARDs and biological agents to patients with inflammatory rheumatic diseases. Clin Exp Rheumatol. 2005;23:5188–94.
   Google Scholar
• Yamanaka H, Inoue E, Singh G, Tanaka E, Nakajima A, Tanig-uchi A, et al. Improvement of disease activity of rheumatoid arthritis patients from 2000 to 2006 in a large observational cohort study IORRA in Japan. Mod Rheumatol. 2007;17(4):283–9.
   Google Scholar
• Badsha H, Kong KO, Tak PP. Rheumatoid arthritis in Dubai-delayed diagnosis and low usage of disease modifying anti-rheumatic drugs. Ann Rheum Dis. 2007;66(6):835.
   PubMedGoogle Scholar